These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21431989)

  • 1. Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-resistant tuberculosis.
    Fox L; Kramer MR; Haim I; Priess R; Metvachuk A; Shitrit D
    Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):863-7. PubMed ID: 21431989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.
    Jagielski T; Augustynowicz-Kopec E; Zozio T; Rastogi N; Zwolska Z
    J Clin Microbiol; 2010 Nov; 48(11):3899-909. PubMed ID: 20810763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    van der Heijden YF; Karim F; Mufamadi G; Zako L; Chinappa T; Shepherd BE; Maruri F; Moosa MS; Sterling TR; Pym AS
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):670-676. PubMed ID: 28482962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.
    Prach LM; Pascopella L; Barry PM; Flood J; Porco TC; Hopewell PC; Metcalfe JZ
    AIDS; 2013 Oct; 27(16):2615-22. PubMed ID: 23842135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.
    Cattamanchi A; Dantes RB; Metcalfe JZ; Jarlsberg LG; Grinsdale J; Kawamura LM; Osmond D; Hopewell PC; Nahid P
    Clin Infect Dis; 2009 Jan; 48(2):179-85. PubMed ID: 19086909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
    Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
    Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drug resistance on the generation of secondary cases of tuberculosis.
    Burgos M; DeRiemer K; Small PM; Hopewell PC; Daley CL
    J Infect Dis; 2003 Dec; 188(12):1878-84. PubMed ID: 14673768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.
    Karo B; Kohlenberg A; Hollo V; Duarte R; Fiebig L; Jackson S; Kearns C; Ködmön C; Korzeniewska-Kosela M; Papaventsis D; Solovic I; van Soolingen D; van der Werf MJ
    Euro Surveill; 2019 Mar; 24(12):. PubMed ID: 30914081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2015 Dec; 70(12):3214-21. PubMed ID: 26311839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients.
    Vadwai V; Shetty A; Soman R; Rodrigues C
    Scand J Infect Dis; 2012 Jan; 44(1):48-50. PubMed ID: 21923626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolone resistance in non-multidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates.
    Ho J; Jelfs P; Sintchenko V
    Int J Infect Dis; 2014 Sep; 26():149-53. PubMed ID: 25086437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Said HM; Peters RPH; Sekyere JO; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.